Show simple item record

TREATMENT OF WILMS TUMOR: A Report from the Turkish Pediatric Oncology Group (TPOG)

dc.contributor.authorMELİKOĞLU, MUSTAFA
dc.contributor.authorYALÇIN, BİLGEHAN
dc.contributor.authorHazar, Volkan
dc.contributor.authorYoruk, Asim
dc.contributor.authorTokuc, Guelnur
dc.contributor.authorAkici, Ferhan
dc.contributor.authorBuyukpamukcu, Nebil
dc.contributor.authorKale, Guelsev
dc.contributor.authorAtahan, Lale
dc.contributor.authorAKYÜZ, CANAN
dc.contributor.authorKarpuzoglu, Guelten
dc.contributor.authorOlgun, Nur
dc.contributor.authorAyan, Inci
dc.contributor.authorOĞUZ, AYNUR
dc.contributor.authorYaris, Nilguen
dc.contributor.authorDagdemir, Ayhan
dc.contributor.authorSander, Serdar
dc.contributor.authorKuyumcuoglu, Ugur
dc.contributor.authorOzseker, Naciye
dc.contributor.authorCorapcioglu, Funda
dc.contributor.authorTanyeli, Atilla
dc.contributor.authorDuezovali, Oeznur
dc.contributor.authorAydin, G. Burca
dc.contributor.authorBuyukpamukcu, Muenevver
dc.contributor.authorDervisoglu, Serguelen
dc.contributor.authorAtkovar, Guelyuez Akyil
dc.contributor.authorBuyukunal, Cenk
dc.contributor.authorDarendeliler, Emin
dc.contributor.authorYildiz, Inci
dc.date.accessioned2021-03-03T19:18:08Z
dc.date.available2021-03-03T19:18:08Z
dc.date.issued2010
dc.identifier.citationAKYÜZ C., YALÇIN B., Yildiz I., Hazar V., Yoruk A., Tokuc G., Akici F., Buyukpamukcu N., Kale G., Atahan L., et al., "TREATMENT OF WILMS TUMOR: A Report from the Turkish Pediatric Oncology Group (TPOG)", PEDIATRIC HEMATOLOGY AND ONCOLOGY, cilt.27, sa.3, ss.161-178, 2010
dc.identifier.issn0888-0018
dc.identifier.otherav_53ce7f7f-4915-4291-bfc4-4f6ff48158f1
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/59387
dc.identifier.urihttps://doi.org/10.3109/08880010903447375
dc.description.abstractAim: To standardize diagnosis and treatment of childhood Wilms tumor (WT) in Turkey. Methods and patients: Between 1998 and 2006, WT patients were registered from 19 centers. Patients 2 years had significantly more advanced disease. 1/11 cases with recurrent disease died; 2/165 had progressive disease, 2/165 had secondary cancers, and all 4 died. In all cases 4-year OS and EFS were 92.8 and 86.5%, respectively. Both OS and EFS were significantly worse in stage IV. Conclusions: Despite problems in patient management and follow-up, treatment results were encouraging in this first national experience with a multicentric study in pediatric oncology. Revisions and modifications are planned to further improve results and minimize short- and long-term side effects.
dc.language.isoeng
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectHematoloji
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectHEMATOLOJİ
dc.subjectPEDİATRİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.titleTREATMENT OF WILMS TUMOR: A Report from the Turkish Pediatric Oncology Group (TPOG)
dc.typeMakale
dc.relation.journalPEDIATRIC HEMATOLOGY AND ONCOLOGY
dc.contributor.departmentHacettepe Üniversitesi , Kanser Enstitüsü ,
dc.identifier.volume27
dc.identifier.issue3
dc.identifier.startpage161
dc.identifier.endpage178
dc.contributor.firstauthorID195752


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record